Journal of Clinical Pharmacology and Toxicology is using Editorial Tracking System to maintain quality and transparency to the author in the peer-review process. Review processing will be performed by the editorial board members of the Journal of Clinical Pharmacology and Toxicology or by Reviewers (outside experts in the field). Two independent reviewer’s approval (Minimum reviewer’s approval) followed by editor approval is obligatory for acceptance of any manuscript excluding an editorial.

We wish to bring together experts in the fields of technology and pharmacy practice to analyze how future innovations could change the ways in which pharmacists work and provide services to patients. The research topic will not consider individual technologies per se. For instance, we will not publish studies that evaluate whether a novel phone app is effective unless they analyze the relationship between that technology and pharmacy practice. Instead, we will focus on new technologies that: (i) are implemented in a pharmacy-related setting (hospital/community pharmacy or in primary care by a pharmacist), (ii) enable pharmacists in their medicines supply or pharmaceutical care roles; (iii) give pharmacists a leadership role in technology adoption and use outside of pharmacy or directly for patients.

Central to the thinking behind this research topic is the insight that technology is not external to pharmacy practice. Often, new technologies are discussed as separate, stand-alone objects that may be adopted or not. In contrast, we take an inclusive perspective. The whole of pharmacy practice – from dispensing to pharmaceutical care – is interwoven with the use of innumerable technologies, some existing and some innovative. For instance, a pen used to write notes during a pharmaceutical care consultation is an old technology that may be replaced by an unforeseen innovation in the future. To understand how existing and new technologies influence practice, we must: (i) understand how operating procedures and practices use technologies of all types; (ii) evaluate new technologies in a practice setting, and (iii) predict how new technologies can create new practice roles for the profession. For instance, could pharmaceutical care activities be technology-enabled? How do barcode technologies influence the ways in which pharmacists organize the dispensing of drugs? Could pharmacies become local technology hubs for patients of all types, regardless of their need for dispensed drugs? In response to such questions, authors should generate new hypotheses, new models and new evidence that speeds the evolution of pharmacy practice for the benefit of health systems, pharmacists and patients.

On the occasion of its 3 years, Successful Journey, Journal of Clinical Pharmacology and Toxicology decided to provide a partial waiver on its article processing charges to promote quality research from across the nations of the globe to encourage the latest research in the field of Infections, Diseases and Medicine. Journal of Clinical Pharmacology and Toxicology also planning to release a special issue on its new approaches.

Regards

Mary Wilson

Editorial office

Journal of Clinical Pharmacology and Toxicology

E-mail: pharmatoxicol@eclinicalsci.com

Tel & Whats app:  +1-947-333-4405